Mkts

Bio-Rad Laboratories, Inc.

NYSE: BIO
$368.82+10.63 (+2.97%)
As of Nov 18, 2:07 PM ET

Key statistics

Day range
358.00370.65
52-week range
236.73396.23
Today
Open360.30
Previous close368.82
Volume207.7K
Valuation
Market cap9.68B
P/E ratio9.46×
EPS (TTM)37.97
Income & risk
Dividend / yield—
Beta1.07
Avg volume266.3K
Discussion

BIO News

Stories mentioning BIO from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue592,100693,200653,000651,600585,400649,700638,500
Cost of Goods Sold282,700348,000309,600306,300279,400293,800283,400
Gross Profit309,400345,200343,400345,300306,000342,000355,900355,100
Operating Expenses
Research & Development62,90070,30071,30060,50073,50079,60091,00058,900
Sales General & Admin212,400221,000206,800207,700208,800204,000200,400194,700
Total Operating Expenses
Operating Income (Loss)34,100(118,900)65,30077,10023,70058,40064,500101,500
Interest Income
Interest Expense12,30012,10012,30012,60012,00012,20012,10012,300
Other Expense24,20028,6008,30016,20037,20019,60017,90018,200
Pretax Income(689,800)929,200(431,100)414,00083,400(908,900)861,600(2,786,300)
Tax Provision(162,700)209,200(89,200)96,20019,400(193,100)208,400(620,800)
Net Income (Loss)(527,100)720,000(341,900)317,80064,000(715,800)653,200(2,165,500)
Earnings Per Share (Basic)(19.55)26.41(12.70)11.672.29(25.57)23.37(76.26)
Earnings Per Share (Diluted)(19.55)26.39(12.70)11.672.29(25.57)23.34(76.26)
Weighted Average Shares Outstanding (Basic)26,95827,26326,92327,22627,94128,21427,94928,395
Weighted Average Shares Outstanding (Diluted)26,95827,28126,92327,22827,95528,21427,98528,395

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About BIO

Bio-Rad Laboratories, Inc. (NYSE: BIO) is a stock listed on the New York Stock Exchange under the ticker symbol BIO. It last traded at $368.82 (Nov 18, 2026, 2:07 PM ET), up 3.0% on the day. That gives Bio-Rad Laboratories a market capitalisation of $9.7B and a price-to-earnings ratio of 9.5.

Over the past 52 weeks BIO has traded between $236.73 and $396.23.

Revenue for the quarter ended Mar 31, 2026 was $592.1M; a net loss of $527.1M. Revenue was up 1.1% from $585.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$592.1M-$527.1M-89.0%
Dec 31, 2025$693.2M$720.0M103.9%
Sep 30, 2025$653.0M-$341.9M-52.4%
Jun 30, 2025$651.6M$317.8M48.8%

From Bio-Rad Laboratories’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…